Market Tracker

05/28 6:01pm ET

Actavis PLC (NYSE:ACT)

During the Trading Day
313.08 +6.29 / +2.05%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
313.13 +0.05 / +0.02%
 
Volume: 30.7K

Today’s Trading

Previous close306.79
Today’s open308.79
Day’s range308.41 - 315.00
Volume3,943,837
Average volume (3 months)2,983,164
Market cap$120.5B
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.45%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.40-0.70%
BMYBristol-Myers Squibb+0.75+1.10%
GSKGlaxoSmithKline+0.18+0.40%
SNYSanofi-0.14-0.28%
Data as of 4:04pm ET, 05/28/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$4.36
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts